These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1825431)

  • 1. Lipoxygenase products in myeloproliferative disorders: increased leukotriene C4 and decreased lipoxin formation in chronic myeloid leukemia.
    Stenke L; Näsman-Glaser B; Edenius C; Samuelsson J; Palmblad J; Lindgren JA
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():883-6. PubMed ID: 1825431
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoxin formation in human platelets.
    Edenius C; Forsberg I; Stenke L; Lindgren JA
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():97-100. PubMed ID: 1847789
    [No Abstract]   [Full Text] [Related]  

  • 3. On the mechanism of transcellular lipoxin formation in human platelets and granulocytes.
    Edenius C; Stenke L; Lindgren JA
    Eur J Biochem; 1991 Jul; 199(2):401-9. PubMed ID: 1906402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia.
    Stenke L; Edenius C; Samuelsson J; Lindgren JA
    Blood; 1991 Dec; 78(11):2989-95. PubMed ID: 1659470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxin formation: evaluation of the role and actions of leukotriene A4.
    Serhan CN; Sheppard KA; Fiore S
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():54-62. PubMed ID: 2169183
    [No Abstract]   [Full Text] [Related]  

  • 6. Formation and effects of leukotrienes and lipoxins in human bone marrow.
    Lindgren JA; Stenke L; Mansour M; Edenius C; Laurén L; Näsman-Glaser B; Ericsson I; Reizenstein P
    J Lipid Mediat; 1993; 6(1-3):313-20. PubMed ID: 8357990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered arachidonate metabolism by leukocytes and platelets in myeloproliferative disorders.
    Takayama H; Okuma M; Kanaji K; Sugiyama T; Sensaki S; Uchino H
    Prostaglandins Leukot Med; 1983 Nov; 12(3):261-72. PubMed ID: 6318227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased leukotriene C4 production in chronic myelogenous leukemia.
    Stenke L; Reizenstein P; Lindgren JA
    Acta Oncol; 1988; 27(6b):803-5. PubMed ID: 2852946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.
    Serhan CN; Sheppard KA
    J Clin Invest; 1990 Mar; 85(3):772-80. PubMed ID: 2155925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced 12-lipoxygenase activity in platelets of patients with myeloproliferative disorders.
    Okuma M; Kanaji K; Ushikubi F; Uchino H; Murakami J; Yoshimoto T; Yamamoto S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():148-51. PubMed ID: 2526460
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet-granulocyte interactions and the production of leukotrienes and lipoxins.
    Lindgren JA; Edenius C
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():63-70. PubMed ID: 2169184
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoxin biosynthesis and actions: role of the human platelet LX-synthase.
    Serhan CN; Romano M
    J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):293-306. PubMed ID: 8777573
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoxin synthesis by arachidonate 5-lipoxygenase purified from porcine leukocytes.
    Ueda N; Yamamoto S; Fitzsimmons BJ; Rokach J
    Biochem Biophys Res Commun; 1987 Apr; 144(2):996-1002. PubMed ID: 3579953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin synthase activity of human platelet 12-lipoxygenase.
    Romano M; Chen XS; Takahashi Y; Yamamoto S; Funk CD; Serhan CN
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):127-33. PubMed ID: 8250832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of novel dihydroxyeicosatetraenoic acids in human platelets: identification of 11, 12-DHETEs and 5, 12-DHETEs.
    Westlund P
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():99-104. PubMed ID: 2821773
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoxin and leukotriene production during receptor-activated interactions between human platelets and cytokine-primed neutrophils.
    Fiore S; Romano M; Serhan CN
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():93-6. PubMed ID: 1825593
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 12-hydroxy- and 12-hydroperoxy-5,8,10,14-eicosatetraenoic acids on the synthesis of 5-hydroxy-6,8,11,14-eicosatetraenoic acid and leukotriene B4 in human blood leukocytes.
    Maclouf J; Fruteau de Laclos B; Borgeat P
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():159-62. PubMed ID: 6221520
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neutrophil function in hematologic disorders].
    Matzner Y
    Harefuah; 1991 Dec; 121(11):449-52. PubMed ID: 1786895
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in the study of lipoxin and leukotriene].
    Wu SH
    Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):79-81. PubMed ID: 8731993
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent progress in the chemistry and biochemistry of lipoxygenase products: the lipoxins.
    Rokach J; Fitzsimmons BJ; Leblanc Y; Ueda N; Yamamoto S
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():761-7. PubMed ID: 2960187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.